Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention (CHAMPION PHOENIX)

NCT01156571 is registered in ClinicalTrials.gov with The Medicines Company as lead sponsor.

NCT NCT01156571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01156571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention (CHAMPION PHOENIX)
Lead sponsor
The Medicines Company
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2010
Completion date
December 31, 2012
Enrollment
11,145 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, atherosclerosis, percutaneous coronary intervention